[ad_1]
Last minute … Member of the Scientific Committee Prof. Dr. Serhat Unal, the market found on Monday night in a critical statement about the exit and described that the coronavirus vaccine will arrive in Turkey.
Prof. Dr. Unal’s statements are as follows:
“Phase 3 studies of the inactivated virus vaccine called CoronaVac, produced by the Chinese company SinoVac, were launched in our country on September 14. The safety data of more than 900 people was examined and we started doing it for our citizens in the second part, which is on November 18.
The 95 percent confidence interval is standard in such studies. The WHO considers this to be 50 percent sufficient. 91 percent will increase in the coming days. Reds are the number of patients in the vaccine arm, blue is the number of patients in the placebo arm. From the 21st the difference arises.
Six of the 26 cases in the placebo arm were treated as severe cases. On the other hand, 3 people in the vaccine arm, 3 members of the medical staff, none of them presented any symptoms, much less hospitalization, and in one case a slight runny nose.
class = “cf”>
The most common side effects are fatigue, headache, pain at the injection site. A friend of ours with the vaccine had a mild allergic reaction and was treated immediately. Other than that, there were no serious side effects. Our vaccine seems safe.
ARE CASES INCREASING IN CHILDREN?
Scientific Committee Member and Pediatric Infections Specialist Prof. Dr. Ateş Kara said the following about the Mis-C syndrome interview in children:
class = “cf”>
“There is an increase in MIS-C in children. As the number of cases in the community increases, the number of children with the virus increases. Today, the cases in MIS-C have started to decrease.
Children don’t develop many symptoms, especially when they contract the Covid-19 virus, but their bodies develop a response to this. Like redness in their eyes, overalls on their hearts, rash on their skin. That is the table we call MISC-.
He says that the infectivity of the virus has increased, evaluations on the mutation in the UK, but this has not been exactly proven. The number of the virus will inevitably increase in children, but this was not seen as an increase in the number of children with cases in the UK. We do not have a reflection such as an increase in the number of cases in children ”.
